These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 6906983)
1. Drug data: intravenous admixtures. Mar DD Am J Nurs; 1981 Mar; 81(3):574-5. PubMed ID: 6906983 [No Abstract] [Full Text] [Related]
2. Evaluation of the literature on stability and compatibility of parenteral admixtures. Trissel LA NITA; 1985; 8(5):365-9. PubMed ID: 3900815 [No Abstract] [Full Text] [Related]
3. Editorial: Contamination of intravenous fluids. N Z Med J; 1975 Mar; 81(535):259. PubMed ID: 1055324 [No Abstract] [Full Text] [Related]
4. Intravenous drug incompatibilities. Morris ME Am J Nurs; 1979 Jul; 79(7):1288-91. PubMed ID: 36757 [No Abstract] [Full Text] [Related]
6. Editorial: Solving problems associated with large-volume parenterals. I: pharmacist responsibility for compounding intravenous admixtures. Zellmer WA Am J Hosp Pharm; 1975 Mar; 32(3):255. PubMed ID: 1136972 [No Abstract] [Full Text] [Related]
7. Chemical incompatibility of parenteral drug admixtures. McCarthy TJ S Afr Med J; 1974 Sep; 48(46):1951-3. PubMed ID: 4421027 [No Abstract] [Full Text] [Related]
15. Compatibility guide for combining IV medications. Ng PK Am J Nurs; 1979 Jul; 79(7):1292-5. PubMed ID: 256451 [No Abstract] [Full Text] [Related]
16. In-use contamination of intravenous solutions in flexible plastic containers. Letcher KI; Thrupp LD; Schapiro DJ; Boersma JE Am J Hosp Pharm; 1972 Aug; 29(8):673-7. PubMed ID: 4626385 [No Abstract] [Full Text] [Related]
17. Technique for microbiological testing of in-use intravenous solutions and administration sets. Lim JC Am J Hosp Pharm; 1979 Sep; 36(9):1202-4. PubMed ID: 386787 [No Abstract] [Full Text] [Related]
18. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Part 2. Allen LV; Stiles ML Am J Hosp Pharm; 1981 Mar; 38(3):380-1. PubMed ID: 7223755 [No Abstract] [Full Text] [Related]
19. Effect of laminar air flow and clean-room dress on contamination rates of intravenous admixtures. Brier KL; Latiolais CJ; Schneider PJ; Moore TD; Buesching WJ; Wentworth BC Am J Hosp Pharm; 1981 Aug; 38(8):1144-7. PubMed ID: 7270557 [TBL] [Abstract][Full Text] [Related]
20. Bretylium tosylate intravenous admixture compatibility. I: Stability in common large-volume parenteral solutions. Lee YC; Baaske DM; Amann AH; Carter JE; Mooers MA; Wagenknecht DM; Lai CM Am J Hosp Pharm; 1980 Jun; 37(6):803-8. PubMed ID: 7395875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]